Ackermans & Van Haaren N.V.
AVHNY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.71 | -0.29 | 0.10 | 0.16 |
| FCF Yield | 20.50% | 4.29% | 3.84% | 9.34% |
| EV / EBITDA | 9.64 | 13.05 | 19.81 | 12.57 |
| Quality | ||||
| ROIC | 2.26% | 2.16% | 1.84% | 1.96% |
| Gross Margin | 34.62% | 34.30% | 34.81% | 37.47% |
| Cash Conversion Ratio | 2.95 | 1.52 | 1.09 | 2.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.15% | 6.58% | 4.02% | 0.28% |
| Free Cash Flow Growth | 406.47% | 7.47% | -56.32% | 32.02% |
| Safety | ||||
| Net Debt / EBITDA | 5.34 | 8.24 | 11.42 | 7.49 |
| Interest Coverage | 7.53 | 7.31 | 8.36 | 10.15 |
| Efficiency | ||||
| Inventory Turnover | 10.19 | 2.87 | 7.36 | 5.62 |
| Cash Conversion Cycle | 99.17 | 211.36 | 141.42 | 86.79 |